...
首页> 外文期刊>Regulatory Toxicology and Pharmacology: RTP >Subchronic oral toxicity study of Korean red ginseng extract in Sprague-Dawley rats with a 4-week recovery period
【24h】

Subchronic oral toxicity study of Korean red ginseng extract in Sprague-Dawley rats with a 4-week recovery period

机译:Sprague-Dawley大鼠韩国红人参提取物的次级口腔毒性研究,4周恢复期

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Ginseng is a major herbal remedy used in Asian countries for thousands of years and known to restore and enhance vital energy. Korean red ginseng, which is processed by steaming and drying fresh Panax ginseng, is most popular and contains unique ginsenosides, which have anticancer and anti-inflammatory properties. The present study was carried out to evaluate the repeated oral dose toxicity of Korean red ginseng extract. The test article was administered orally once a day to male and female Sprague-Dawley rats at dose levels of 0, 500, 1000, or 2000 mg/kg/day for 13 consecutive weeks (15 animals/sex/group in the vehicle control and 2000 mg/kg/day groups, and 10 animals/sex/group in the 500 and 1000 mg/kg/day groups). Ten animals per group were sacrificed at the end of the 13-week treatment period, and the remaining rats were sacrificed after a 4-week recovery period. Administration of Korean red ginseng extract did not result in any toxicologically significant changes in mortality, body weight, food consumption, ophthalmoscopy, hematology, serum biochemistry, gross pathological findings, absolute/relative organ weights, or histopathology. It was established that the no observed adverse effect level (NOAEL) of the test article was 2000 mg/kg/day for both sexes in this study.
机译:人参是亚洲国家在亚洲国家使用的主要草药疗法成千上万年,并已知恢复和增强重要的能量。韩国红人参,由蒸汽和干燥新鲜的Panax人参,最受欢迎,含有独特的人参皂苷,具有抗癌和抗炎性质。本研究进行了评价韩国红人参提取物的重复口服剂量毒性。测试制品在连续13周(车辆控制中15只动物/性/群和2000毫克/千克/天群和500和1000毫克/千克/天群中的10只动物/性/群)。在13周治疗期结束时,每组中牺牲每组10只动物,剩余的大鼠在4周的恢复期后处死。韩国红人参提取物不会导致死亡,体重,食品消费,眼科检查,血液学,血清生物化学,病理发现,绝对/相对器官重量或组织病理学的任何毒理学上显着的变化。确定这项研究中的两种性别的测试制品的未观察到的不良反应水平(NOAEL)为2000毫克/千克/天。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号